Literature DB >> 1555250

Interleukin-6 is used as a growth factor by virulent Mycobacterium avium: presence of specific receptors.

M Denis1.   

Abstract

In this paper, we examined the contribution of the lymphokine interleukin-6 (IL-6) to the growth of four virulent strains of Mycobacterium avium and the nature of the binding moieties on the mycobacteria. First, we showed that human or mouse recombinant interleukin-6 are potent growth factors for four strains of virulent M. avium. This was shown to occur in tissue culture medium, which does not support maximal growth of M. avium. Bioactive IL-6 was required, inasmuch as heat-activating IL-6 or adding an antibody against IL-6 blocked this growth-enhancing ability. The rapid uptake of IL-6 by M. avium was indicated by the fact that the incubation of IL-6 with the four M. avium strains led to a rapid removal of the bioactivity from the culture medium and a rapid removal of radiolabeled IL-6. Scatchard analysis of receptor interaction showed that the M. avium strains had a single receptor species with a Kd of 50 nM and the number of receptor sites was approximately 15,000 bacterium. Blocking experiments showed that the binding of radiolabeled IL-6 was fully displaceable with cold IL-6, but not with other lymphokines. These data suggest that IL-6 may play an important role in the pathogenesis of M. avium infections, notably by promoting growth of M. avium, and that some virulent M. avium strains bind IL-6 in a specific manner.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555250     DOI: 10.1016/0008-8749(92)90137-e

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  Bacterial perturbation of cytokine networks.

Authors:  M Wilson; R Seymour; B Henderson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.

Authors:  H Tomioka; K Sato; T Shimizu; C Sano; T Akaki; H Saito; K Fujii; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  Interleukin-1 is involved in mouse resistance to Mycobacterium avium.

Authors:  M Denis; E Ghadirian
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response.

Authors:  W Chen; E A Havell; F Gigliotti; A G Harmsen
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

5.  Release of TNF alpha and IL6 from human monocytes infected with Mycobacterium kansasii: a comparison to Mycobacterium avium.

Authors:  F Stauffer; E P Petrow; H Burgmann; W Graninger; A Georgopoulos
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

6.  Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.

Authors:  J Champsi; L S Young; L E Bermudez
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

7.  Interleukin-6: a potent biomarker of mycobacterial infection.

Authors:  Prati Pal Singh; Amit Goyal
Journal:  Springerplus       Date:  2013-12-21

8.  Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils.

Authors:  Bozena Dziadek; Anna Brzostek; Marcin Grzybowski; Marek Fol; Agnieszka Krupa; Jakub Kryczka; Przemyslaw Plocinski; Anna Kurdowska; Jaroslaw Dziadek
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.